News & Press Releases
Filter by:
What Is Going On With The SEC Climate Rule Litigation?
March 20, 2024
In a recent Responsible Investor article, ESG Co-chair Jacob Hupart shared his insights on the ongoing litigation surrounding the SEC’s climate disclosure rule, addressing the various challenges and uncertainty around the rule’s future.
Is It A Bad Thing That ERISA Killed The Pension Plan?
March 19, 2024
Of Counsel Michelle Capezza spoke with Fiduciary News providing insights on the Employee Retirement Income Security Act (ERISA) and whether it unintentionally contributed to the decline of traditional pension programs.
Toronto Managing Partner Mitch Frazer spoke to Benefits Canada on the complexities of the Canada Revenue Agency’s guidance for determining a full-time remote employee’s province of employment for payroll deduction purposes.
Healthy Returns: What’s Next In The Legal Fight Over Medicare Drug Price Negotiations
March 13, 2024
CNBC spoke with Member Theresa Carnegie on the legal battle over Medicare drug price negotiations. Drug makers argue that such negotiations would force them to sell medicine at significant discounts, violating their due process under the Fifth Amendment. Theresa commented on the government’s initial victories and their potential impact on remaining legal challenges.
ESG Co-chair Jacob Hupart spoke to E&E News providing insight on the new SEC rule aimed at improving transparency in corporate climate reporting and how it will impact the comparability of data across different firms.
Side Letter: CalPERS' Co-invest Conviction
March 12, 2024
Private Equity Co-Chair Matthew T. Simpson spoke with Private Equity International on trends in private equity and the potential implications for mid-market private equity sponsors.
